Malin Jarvius
Senior research engineer at Department of Pharmaceutical Biosciences; Research; Pharmaceutical Bioinformatics
- E-mail:
- malin.jarvius@uu.se
- Visiting address:
- Biomedicinskt centrum BMC, Husargatan 3
- Postal address:
- Box 591
751 24 UPPSALA
Publications
Recent publications
-
The method developer's guide to oligonucleotide design
Part of Expert Review of Proteomics, p. 65-80, 2024
- DOI for The method developer's guide to oligonucleotide design
- Download full text (pdf) of The method developer's guide to oligonucleotide design
-
Part of SLAS TECHNOLOGY, 2024
- DOI for Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models
- Download full text (pdf) of Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models
-
Discovery of a novel inhibitor of macropinocytosis with antiviral activity
Part of Molecular Therapy, p. 3012-3024, 2024
- DOI for Discovery of a novel inhibitor of macropinocytosis with antiviral activity
- Download full text (pdf) of Discovery of a novel inhibitor of macropinocytosis with antiviral activity
-
Part of BMC Pharmacology & Toxicology, 2024
- DOI for Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment
- Download full text (pdf) of Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment
-
Part of BMC Cancer, 2023
- DOI for Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death
- Download full text (pdf) of Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death
All publications
Articles in journal
-
Part of SLAS TECHNOLOGY, 2024
- DOI for Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models
- Download full text (pdf) of Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models
-
Discovery of a novel inhibitor of macropinocytosis with antiviral activity
Part of Molecular Therapy, p. 3012-3024, 2024
- DOI for Discovery of a novel inhibitor of macropinocytosis with antiviral activity
- Download full text (pdf) of Discovery of a novel inhibitor of macropinocytosis with antiviral activity
-
Part of BMC Pharmacology & Toxicology, 2024
- DOI for Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment
- Download full text (pdf) of Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment
-
Part of BMC Cancer, 2023
- DOI for Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death
- Download full text (pdf) of Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death
-
Part of Nature Cancer, p. 156, 2022
- DOI for Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress
- Download full text (pdf) of Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress
-
Single-cell transcriptional pharmacodynamics of trifluridine in a tumor-immune model
Part of Scientific Reports, 2022
- DOI for Single-cell transcriptional pharmacodynamics of trifluridine in a tumor-immune model
- Download full text (pdf) of Single-cell transcriptional pharmacodynamics of trifluridine in a tumor-immune model
-
Part of Scientific Reports, 2022
- DOI for Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma
- Download full text (pdf) of Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma
-
Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
Part of Scientific Reports, 2020
- DOI for Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
- Download full text (pdf) of Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway
-
Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
Part of BMC Research Notes, 2019
- DOI for Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
- Download full text (pdf) of Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
-
Part of BMC Bioinformatics, 2019
- DOI for COMBImage2: a parallel computational framework for higher-order drug combination analysis that includes automated plate design, matched filter based object counting and temporal data mining
- Download full text (pdf) of COMBImage2: a parallel computational framework for higher-order drug combination analysis that includes automated plate design, matched filter based object counting and temporal data mining
-
Part of Journal of Pathology, p. 228-240, 2019
-
Part of Journal of Pathology, p. 295-307, 2019
-
Part of BMC Bioinformatics, 2018
- DOI for COMBImage: a modular parallel processing framework for pairwise drug combination analysis that quantifies temporal changes in label-free video microscopy movies
- Download full text (pdf) of COMBImage: a modular parallel processing framework for pairwise drug combination analysis that quantifies temporal changes in label-free video microscopy movies
-
Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin
Part of Cell Reports, p. 977-990, 2017
- DOI for Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin
- Download full text (pdf) of Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin
-
Part of Cancer Research, p. 802-812, 2017
-
Targeting tumor cells based on Phosphodiesterase 3A expression
Part of Experimental Cell Research, p. 308-315, 2017
-
Part of Immunopharmacology and immunotoxicology, p. 199-210, 2017
-
Part of Cell Reports, p. 2994-3009, 2016
- DOI for Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition
- Download full text (pdf) of Clonal Variation in Drug and Radiation Response among Glioma-Initiating Cells Is Linked to Proneural-Mesenchymal Transition
-
Part of CELL CHEMICAL BIOLOGY, p. 1428-1438, 2016
-
Part of Blood Cancer Journal, 2015
- DOI for Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
- Download full text (pdf) of Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
-
Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
Part of PLOS ONE, 2015
- DOI for Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
- Download full text (pdf) of Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
-
Part of Molecular Therapy, 2014
-
Part of Biochemical Pharmacology, p. 284-291, 2014
- DOI for AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia
- Download full text (pdf) of AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia
-
Repositioning of Quinacrine for Treatment of Acute Myeloid Leukemia
Part of Blood, 2014
-
Part of BMC Cancer, p. 374, 2013
- DOI for Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance
- Download full text (pdf) of Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance
-
Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells
Part of Biochemical and Biophysical Research Communications - BBRC, p. 117-123, 2013
-
VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts
Part of EMBO Journal, p. 1377-1388, 2010
-
Part of Molecular & Cellular Proteomics, p. 178-183, 2010
-
Platelet-derived growth factor receptor expression and activation in choroid plexus tumors
Part of American Journal of Pathology, p. 1631-1637, 2009
-
Part of Methods, p. 227-32, 2008
-
Part of Molecular & Cellular Proteomics, p. 1500-1509, 2007
-
Direct observation of individual endogenous protein complexes in situ by proximity ligation
Part of Nature Methods, p. 995-1000, 2006
Articles, review/survey
-
The method developer's guide to oligonucleotide design
Part of Expert Review of Proteomics, p. 65-80, 2024
- DOI for The method developer's guide to oligonucleotide design
- Download full text (pdf) of The method developer's guide to oligonucleotide design
-
Proximity ligation assays: a recent addition to the proteomics toolbox
Part of Expert Reviews of Proteomics, p. 401-409, 2010
-
Proximity ligation assays for sensitive and specific protein analyses.
Part of Anal Biochem, p. 2-9, 2005
Chapters in book
-
Part of Molecular Diagnostics, p. 299-306, Elsevier/Academic Press, 2010
-
Proximity ligation: a specific and versatile tool for the proteomic era.
Part of Genet Eng (N Y)., p. 190, Springer, 2007